contact - WHO
Contact n°183 –Autumn/Winter 2006 3 EDITORIAL wards changing specific problems; the amount of irrational use, so that the size of the problem is known and the impact of the strategies can be moni-tored; the reasons why medicines are used irrationally, so that appropriate, effective
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Documents from same domain
Regulatory Situation of Herbal Medicines A …
apps.who.intRegulatory Situation of Herbal Medicines A worldwide Review FOREWORD Although modern medicine is well developed in most of the world, large sections of the
Review, Regulatory, Medicine, Worldwide, Situation, Herbal, Regulatory situation of herbal medicines a, Regulatory situation of herbal medicines a worldwide review
WHO monographs on medicinal plants commonly …
apps.who.intWHO Library Cataloguing-in-Publication Data WHO monographs on medicinal plants commonly used in the Newly Independent States (NIS). 1.Plants, Medicinal. 2.Medicine, Traditional. 3.Angiosperms. 4.Commonwealth of Independent States.
Monographs, Plants, Medicinal, Who monographs on medicinal plants commonly, Commonly
chapter 44 Medical stores management - WHO
apps.who.intchapter 44 Medical stores management Summary 44.2 44.1 Information for materials management 44.2 Manual versus computerized systems • Figure 44-2Procurement
Management, Medical, Chapter, Chapter 44 medical stores management, Stores
WHO guidelines for assessing
apps.who.intvii Foreword The use of medicinal plants for treating diseases is probably the oldest existing method that humanity has used to try to cope with illness.
Guidelines, Assessing, Plants, Medicinal, Medicinal plants, Who guidelines for assessing
Annex 9 - World Health Organization
apps.who.intAnnex 9 Guide to good storage practices for pharmaceuticals1 1. Introduction 1 2. Glossary 2 3. Personnel 3 4. Premises and facilities 4 5. Storage requirements 5
Pharmaceutical regulation: A twelve country study …
apps.who.intThis document should be considered a draft report as not all of the data presented has been officially endorsed by national authorities Page 2
Pharmaceutical, Country, Regulations, Pharmaceutical regulation, A twelve country, Twelve
Annex 2 Stability testing of active pharmaceutical ...
apps.who.int88 1. Introduction 1.1 Objectives of these guidelines These guidelines seek to exemplify the core stability data package required for registration of active pharmaceutical ingredients (APIs) and
Pharmaceutical, Testing, Active, Ingredients, Active pharmaceutical ingredients, Stability testing of active pharmaceutical, Stability
MOHFormulary Drug List - WHO
apps.who.int8 9 INTRODUCTION USE of FORMULARY MOH Formulary Drug List Is Divided Into Three Sections. The First Section Is a Compilation of Selected Policies , Guidelines,
The Logistics Handbook - WHO
apps.who.intThe Logistics Handbook A Practical Guide for the Supply Chain Management of Health Commodities 2011 . This publication was produced for review by the U.S. Agency for International Development.
Management, Handbook, Supply, Logistics, The logistics handbook
Related documents
chapter 4 National medicine policy - WHO
apps.who.int4 / National medicine policy 4.3 stated: a national medicine policy should ensure that effec- tive and safe medicines of good quality are accessible and affordable to the entire population and that they are - ratio nally used. The 1980s saw the idea of an NMP emerging as a posi-tive concept, and the World Health Organization (WHO)
(OWTOIMPROVETHEUSEOF - WHO
www.who.inti (OWTOIMPROVETHEUSEOF MEDICINESBYCONSUMERS Andrew Chetley Healthlink Worldwide Anita Hardon University of Amsterdam Catherine Hodgkin Royal Tropical Institute, the Netherlands
Sunoion Support
www.sunovionsupport.com2 Sunoion Support® PSPN ASSSAN PGAM Patient’s Insurance Information 1. Is the patient enrolled in Medicare/Medicaid? YES NO 2. Does the patient have prescription drug coverage through any other benefit program that helps pay for prescription
Dental management of patients before and after renal ...
www.sbdmj.comStomatologija, Baltic Dental and Maxillofacial Journal, 2011, Vol. 13, No. 4 107 Dental management of patients before and after renal transplantation
Patients, Management, Before, Learn, After, Dental, Dental management of patients before, Dental management of patients before and after renal transplantation, Transplantation
Vaccine Fact Sheet - EZIZ
eziz.orgBrand Name Menactra Manufacturer Abbreviation MenACWY-CRM Protects Against Invasive Meningococcal Disease caused by Routine Schedule One (1) dose at …
Developing Data Collection Instruments - World Bank
siteresources.worldbank.org103 8 Developing Data Collection Instruments M onitoring and evaluation rely on data collection instruments to elicit and record information. There are various types of instruments
Data, Developing, Instruments, Collection, Developing data collection instruments
Financial Section - Merck.com
www.merck.com20 Merck & Co., Inc. Annual Report 2002 live virus vaccine for the prevention of chickenpox, M-M-R II, a pediatric vaccine for measles, mumps and rubella, and
Generic and Brand Name Drugs: Understanding the Basics
www.dbsalliance.orgGeneric and Brand Name Drugs: Understanding the Basics We’ve been there. We can help.